Skip to content

Schrodinger SDGR Accounts Payable

Accounts Payable at other companies

Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$20.35M-18.9%
Absci Corporation logo
Absci CorporationABSI
$8.83M+78.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$20.81M-36.6%
Certara, Inc. logo
Certara, Inc.CERT
$3.69M-27.2%
Septerna, Inc. logo
Septerna, Inc.SEPN
$7.46M+71.6%
Revvity logo
RevvityRVTY
$169.68M-4.7%

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-23.7%
Enterprise value$984.71M-23.1%
P/S4.5×-2.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's accounts payable?
Schrodinger (SDGR) reported accounts payable of $11.95M in Q1 2026.
How has Schrodinger's accounts payable changed year-over-year?
Schrodinger's accounts payable increased by 0.7% year-over-year, from $11.86M to $11.95M.
What is the long-term trend for Schrodinger's accounts payable?
Over 4 years (2021 to 2025), Schrodinger's accounts payable has grown at a 8.8% compound annual growth rate (CAGR), from $29.49M to $41.33M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.